Vivani Medical Inc.

VANI | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.29

+$0.05 (+4.03%)

Sep 22, 2026, 11:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $106.93M

Enterprise Value $104.89M

Beta 3.28

Average Volume 381.56K

Shares Outstanding (Diluted) 87.09M

Shares Change YoY 47%

Institutional Ownership 6.90%

Exchange NASDAQ

ISIN US92854B1098

Price Performance

Price Change 1M -11.4%

Price Change 3M 4.2%

Price Change 6M 9.7%

Price Change YTD -2.4%

Price Change 1Y -20.0%

Price Change 3Y 30.5%

Price Change 5Y -87.7%

1M CAGR (ann.) -12.1%

1Y CAGR (ann.) -15.7%

5Y CAGR (ann.) -34.7%

All-Time CAGR -39.5%

Valuation

PE Ratio -3.54

Forward PE N/A

PEG Ratio -0.14

Forward PEG -0.15

PS Ratio N/A

Forward PS N/A

PB Ratio 5.64

P/FCF Ratio -4.04

P/Adj. FCF Ratio -3.84

P/OCF Ratio -4.28

EV/Sales N/A

EV/EBIT -3.84

EV/EBITDA -3.89

EV/FCF -3.96

Earnings Yield -28.2%

FCF Yield -24.8%

Adj. FCF Yield -26.1%

Financial Health

Net Cash $2.04M

Total Debt $17.86M

Cash & Short-Term Investments $19.89M

Total Assets $41.64M

Current Ratio 3.25

Quick Ratio 3.25

Debt / Equity Ratio 0.94

Debt / EBITDA -0.66

Debt / FCF -0.67

OCF / Debt -1.42

Interest Coverage 0.00

Altman Z-Score -4.34

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5.2%

Returns

Return on Assets -63.2%

Return on Equity -191.1%

Return on Invested Capital -73.9%

Return on Capital Employed -77.8%

Return on Tangible Assets -63.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -40.5%

EPS CAGR 3Y 14.2%

EPS CAGR 5Y -5.2%

EPS CAGR 10Y 33.3%

FCF CAGR 3Y -10.5%

FCF CAGR 5Y -11.2%

FCF CAGR 10Y 1.6%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y -7.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.07

EPS Growth Est (next Q) -36.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $4

Price Target Upside 222.6%

Cash Flow

Operating Cash Flow $-25.3M

Free Cash Flow $-26.5M

Adj. Free Cash Flow $-27.87M

FCF Per Share -$0.30

OCF Per Share -$0.29

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-130K

Operating Income $-27.23M

EBITDA $-26.97M

Net Income $-26.31M

EPS (Diluted) -$0.35

Revenue / Employee N/A

Profit / Employee $-626.5K

Employees 42